Other languages Revvity, Inc.

Equities

RVTY

US7140461093

Market Closed - Nyse Other stock markets 01:30:01 02/05/2024 am IST			5-day change	1st Jan Change
102.6 ^USD	+0.13%		-0.08%	-6.14%

30/04	TD Cowen Adjusts Price Target on Revvity to $130 From $123	MT
30/04	JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Revvity beats quarterly estimates on demand for diagnostic equipment	29/04
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	29/04
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	29/04
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	26/04
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25/04
Revvity Unveils A New Era of Automated Tuberculosis Testing	24/04
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	02/04
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance	21/03
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	21/03
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	18/03
Revvity, Inc. Introduces New Workflow to Accelerate Newborn Sequencing Research	15/03
Revvity Inc Receives a Shareholder Proposal from John Chevedden	13/03
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions	13/02
Revvity Insider Sold Shares Worth $3,841,563, According to a Recent SEC Filing	08/02
Revvity Insider Sold Shares Worth $1,613,697, According to a Recent SEC Filing	08/02
RECOMENDACIONES DE LOS ANALISTAS EE.UU. : Alphabet, Meta Platforms, Amazon, Wise, Clorox...	02/02
Revvity Showcases Cutting-Edge Solutions at SLAS2024	02/02
Revvity Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance	01/02
Revvity, Inc. Provides Revenue Guidance for the Full Year of 2024	01/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Revvity, Inc.

Equities

RVTY

US7140461093

Other languages

Filters